COVID-19 UPDATE – Our Legal Team is Fully Operational. Serving Existing Clients and Accepting New Cases.

Excessive Chemotherapy Leads to Settlement due to Heightened Risk of Cardiotoxicity

A discovery of a lump in the patient’s right axilla led to a diagnosis of Non-Hodgkin’s lymphoma in this case. Non-Hodgkin’s lymphoma is cancer that originates in your lymphatic system, the disease-fighting network, and then spreads throughout your body. In non-Hodgkin’s lymphoma, tumors develop from lymphocytes – a type of white blood cell. The doctor, in question, breached the standard of care by continuing the client’s CHOP chemotherapy, the most common chemotherapy regimen for treating this type of cancer, beyond eight cycles. By the end of those eight cycles, the patient’s tumor had either gone into remission or become refractory to these agents. Rosen Louik & Perry, Pennsylvania malpractice attorneys consulted medical experts. In our expert doctor’s view, use of CHOP beyond eight cycles was unlikely to benefit the patient and needlessly heightened the risk of the cardiotoxicity. The patient had suffered no damages as of the time of settlement. The case settled for $200,000.00.

Overuse of chemotherapy can have devastating health effects. Rosen Louik & Perry consult with highly regarded medical experts to verify your chemotherapy settlement claim. Call us today for a free case evaluation.